Morning Breakouts

Latest KFF Health News Stories

Substance Abuse Now Accounts For Nearly One Of Three Minnesota Children Being Removed From Their Homes

Morning Briefing

The flood of children entering the state’s care because of the opioid crisis is further straining a system already taxed. Meanwhile, a clinic in Virginia will be the first in the state to provide a program for pregnant women trying to fight addiction.

Drug Could Be An Inexpensive Life Saver For Millions Of African Children With Sickle-Cell Disease

Morning Briefing

There is currently no treatment for sickle-cell disease in Africa. While more research needs to be done on hydroxyurea, a drug invented to fight blood cancers, early tests show the inexpensive, easy-to-give pill is safe. In other international health news, researchers say progress is slowing on eradicating polio.

Mysterious ‘Havana Syndrome’ Strikes Another Canadian Diplomat As Experts Remain Flummoxed

Morning Briefing

The newest case marks the 13th time a Canadian officer or family member has reported these “unusual health symptoms,” while more than 20 Americans have also been affected. In other public health news: cancer treatment, the placenta, Christmas gifts for kids, suicide, gun violence, and more.

‘There Is A Revolution In Migraine’: New Drugs Offering Hope To Patients Who Have Suffered Their Whole Lives

Morning Briefing

This year, the FDA approved three drugs meant to prevent migraines and those, along with less expensive and less invasive techniques to stimulate the body’s response to pain through neurostimulation, are giving optimism to headache specialists and their patients after years of little progress.

Scientist Who Edited Human Embryos Wasn’t Exactly Tight-Lipped About Plans. So, Why Did No One Stop Him?

Morning Briefing

NIH Director Francis Collins called He Jiankui “a scientist who apparently believed that he was a hero. In fact, he crossed every line, scientifically and ethically,” after it was announced that he gene-edited human embryos using CRISPR. The reaction has been echoed across the scientific community for the past week. But were there missed opportunities for others to intervene along the way? Meanwhile, the scandal might have rocked the science world, but Wall Street was unfazed.

After Years Of Rising Deductibles For Workers, Some Employers Are Tapping The Brakes

Morning Briefing

Instead of continuing the trend of passing on the burden of higher costs to employees, some companies are looking to address the underlying reasons for the spending. Among other strategies, some organizations are bypassing insurers and negotiating deals with hospitals directly and a growing number are offering their own clinics. Meanwhile, experiments that work to improve a patient’s social factors, such as housing, are finding big savings.

Building An Empire On The Back Of A Crisis: How This Company Makes Millions Housing Migrant Children

Morning Briefing

Southwest Key has stockpiled tens of millions of taxpayer dollars with little government oversight and possibly engaged in self-dealing with top executives. The New York Times offers a look at the company and its leader, who calls himself El Presidente.

New Emails Reveal How Deeply Involved Shadowy Mar-A-Largo Trio Was On VA Decisions

Morning Briefing

The records show Marvel Entertainment chairman Ike Perlmutter, West Palm Beach physician Bruce Moskowitz and lawyer Marc Sherman editing the budget for a government program, weighing in on job candidates and being treated as decision-makers on policy initiatives. The men are connected to President Donald Trump through his Mar-A-Lago resort.

Amazon Is Trying To Shoulder Its Way Into The Pharmacy Business–But That Might Not Be As Easy As It Expects

Morning Briefing

Health care is an industry that requires a lot of licenses — and it can all get very complicated. In other pharmaceutical news: the blue wave and the drug industry; Gilead’s foray into cancer cell therapy; an experimental blood disease drug; and more.

Investigation Details FDA’s Flawed Oversight Efforts For Orphan Drug Program That’s Particularly Vulnerable To Manipulation

Morning Briefing

The program is part of congressional efforts to motivate pharmaceutical companies to develop drugs for people who lack treatments for their rarer conditions, and it can be very lucrative for the companies. But the GAO uncovered inconsistent and often incomplete reviews by FDA employees early in the process of designating medicines as an orphan drug.

Administration Officials Deny Steering Patients Toward Private Medicare Plans, But Emails Tell A Different Story

Morning Briefing

“Get more benefits for your money,” says one message sent to Medicare beneficiaries. “See if you can save money with Medicare Advantage,” says another. While private plans boast of providing superior-quality care, the evidence is mixed. And experts are worried that the material being sent out by the government doesn’t present the negatives of the plans. Other Medicare news focuses on nursing homes and enrollment.

Brain Changes Seen In Young Football Players After Just One Season Of Playing, Researchers Say

Morning Briefing

The results of the small study suggest that repeated blows to the head could lead to changes critical to integrating cognitive, motor and sensory functions between the two hemispheres of the brain. Other news on children’s concussions focuses on new recovery guidelines.

Ocasio-Cortez Flips ‘Death Panel’ Rhetoric, Arguing That They Already Exist In Private Marketplace

Morning Briefing

The idea that “death panels” will decide when people on Medicare should be cut off from live-saving services has often been used against Democrats, but this weekend Rep.-elect Alexandria Ocasio-Cortez (D-N.Y.) countered that that principle already exists in the current health care system. “They are companies + boards saying you’re on your own bc they won’t cover a critical procedure or medicine,” she tweeted. Meanwhile, Ocasio-Cortez also expressed frustration that Congress can offer cheap health care benefits to its own members yet “would deny other people affordability that they themselves enjoy.”